WGS
GeneDx Holdings Corp.
NASDAQ: WGS · HEALTHCARE · DIAGNOSTICS & RESEARCH
$34.71
+0.58% today
Updated 2026-05-06
Market cap
$1.91B
P/E ratio
—
P/S ratio
4.48x
EPS (TTM)
$-0.73
Dividend yield
—
52W range
$55 – $171
Volume
1.0M
GeneDx Holdings Corp. (WGS) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
8 of 8
Last 8 quarters
Avg EPS surprise
+104.6%
Last 4 quarters
Revenue YoY growth
+26.5%
Most recent quarter
EPS YoY growth
-78.0%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+4.7%
Last 3 reports
Positive reaction rate
67%
2 of 3 quarters
Largest single-day move
+15.0%
2025-07-28
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-02-23 | $0.14 | +58.0% | $82.06 | $80.70 | -1.7% |
| 2025-10-28 | $0.49 | +19.5% | $130.66 | $131.76 | +0.8% |
| 2025-07-28 | $0.50 | +323.7% | $79.83 | $91.78 | +15.0% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $0.09 | $0.14 | +58.0% | $120.99M | +26.5% |
| 2025-09-30 | $0.41 | $0.49 | +19.5% | $116.74M | +51.9% |
| 2025-06-30 | $0.12 | $0.50 | +323.7% | $102.69M | +45.6% |
| 2025-03-31 | $-0.67 | $0.27 | +140.8% | $87.11M | +39.6% |
| 2024-12-31 | $0.10 | $0.64 | +515.0% | $95.64M | +66.6% |
| 2024-09-30 | $-0.21 | $0.04 | +119.0% | $76.87M | +44.2% |
| 2024-06-30 | $-0.30 | $-0.10 | +66.7% | $70.51M | +44.8% |
| 2024-03-31 | $-0.67 | $-0.33 | +50.7% | $62.42M | — |
| 2023-12-31 | $-0.75 | $-0.69 | +8.0% | $57.42M | — |
| 2023-09-30 | $-1.31 | $-0.82 | +37.4% | $53.30M | — |
| 2023-06-30 | $-1.31 | $-1.64 | -25.2% | $48.71M | — |
Frequently asked questions
Has GeneDx Holdings Corp. beaten earnings estimates?
GeneDx Holdings Corp. has beaten Wall Street EPS estimates in 8 of its last 8 quarterly reports, with an average EPS surprise of +104.6% over the last 4 quarters.
How does WGS stock react to earnings?
WGS stock has moved an average of +4.7% in the trading day following earnings over its last 3 reports, with positive reactions in 67% of those quarters.
What is GeneDx Holdings Corp.'s revenue growth rate?
GeneDx Holdings Corp. reported year-over-year revenue growth of +26.5% in its most recent quarter, with EPS growing -78.0% year-over-year.